Women's Imaging

You are here

Women's Imaging

Recent Headlines

Better radiotherapy achieved in breast-cancer patients trained to hold their breath

Breast-cancer patients can learn how to hold their breath for more than five minutes in order to receive radiation therapy while motionless, which can lead to shorter treatments, lower overall doses, better tumor targeting and less destruction of healthy tissue.

Young breast cancer patients run to genetic testing, make proactive choices

The authors of a study published online in JAMA Oncology Feb. 11 are drawing from their “Angelina effect”-supporting data to urge physicians to follow National Comprehensive Cancer Network guidelines by recommending genetic testing and counseling for all breast-cancer patients 50 and younger. 

Imaging software could provide quick breast cancer diagnosis

Imaging software being developed at Rice University in Houston could offer fast, accurate diagnosis of breast cancer without the need for a specialist, according to a study published in Breast Cancer Research.

The ‘Angelina Effect’ is real, and potentially powerful

“I choose not to keep my story private because there are many women who do not know that they might be living under the shadow of cancer. It is my hope that they, too, will be able to get gene tested, and that if they have a high risk they, too, will know that they have strong options.”

FDG PET could forecast breast cancer patients’ response to therapy

Quantitative PET using agents like FDG could predict the outcome of chemotherapy for patients with particularly tricky cases of advanced breast cancer, according to a study published Dec. 4 in the Journal of Nuclear Medicine.

Capturing minute changes in DNA could aid early detection of breast cancer

Targeting oncogene-driven activation of DNA damage could be an effective way to tap into the earliest stages of cancer development, or tumorigenesis. An investigative molecular imaging agent was able to do just that in a preclinical Oxford University study published ahead of print Nov. 13 in the Journal of Nuclear Medicine.

Molecule could identify and aid treatment of aggressive breast cancers

A molecule has been found that could be leveraged to treat the most dangerous cancers of the breast, known as triple negative breast cancer, according to a Nov. 3 announcement from the City College of New York (CCNY).

Sentinel lymph node mapping for ovarian cancer?

With all of the recent expansion of sentinel lymph node mapping for melanoma and breast cancers and now in all solid tumors, some experts are wondering about the value of this technique for ovarian cancer. A study published ahead of print Oct. 20 in the Journal of Nuclear Medicine makes the case.

PET/CT changed diagnosis in 21% of breast cancer patients under 40

Patients less than 40 years of age originally diagnosed with one of the first three stages of breast cancer underwent a change in clinical staging as a result of PET/CT scanning, according to a study announced Oct. 1 by the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

A new prognostic biomarker for breast cancer

A new method of molecular imaging captures the dysfunction of an oncoprotein—Akt/PKB, the activation of which is tied to dismal prognoses in cancer patients. High throughput time-resolved-FRET (fluorescence resonance energy transfer) was implemented to seek out Akt/PKB activation in breast cancer patients, which could have a significant impact on not only future research, but potentially individual patient management, according to a study published in the July issue of Cancer Research.